(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -3.12%43.49B | -3.17%21.28B | 12.72%92.93B | 20.91%69.86B | -2.12%44.89B | -15.49%21.98B | -7.57%82.44B | -6.60%57.78B | 23.65%45.86B | 27.61%26.01B |
Operating income | -3.02%37.5B | -3.17%21.28B | 10.22%80.08B | 20.91%69.86B | -3.69%38.66B | -15.49%21.98B | -4.26%72.65B | -6.60%57.78B | 26.89%40.14B | 27.61%26.01B |
Cost of sales | 5.51%-37.56B | ---- | -7.01%-81.61B | ---- | 2.28%-39.75B | ---- | -2.65%-76.27B | ---- | -31.95%-40.68B | ---- |
Operating expenses | 5.51%-37.56B | 4.69%-17.74B | -7.01%-81.61B | -15.00%-58.96B | 2.28%-39.75B | 12.75%-18.61B | -2.65%-76.27B | -6.78%-51.27B | -31.95%-40.68B | -41.41%-21.33B |
Gross profit | 93.95%-65.93M | 5.26%3.54B | 57.50%-1.53B | 67.44%10.9B | -102.27%-1.09B | -27.99%3.37B | -327.02%-3.61B | -52.98%6.51B | -167.08%-539.03M | -11.72%4.67B |
Selling expenses | 13.75%-130.01M | 15.67%-59.95M | -7.30%-315.54M | -7.63%-227.36M | 16.02%-150.74M | 23.40%-71.09M | 20.14%-294.07M | 34.49%-211.24M | 14.39%-179.49M | 13.88%-92.81M |
Administrative expenses | ---- | 13.00%-453.55M | ---- | 11.75%-1.4B | ---- | 14.58%-521.34M | ---- | 43.93%-1.59B | ---- | 29.42%-610.34M |
Research and development expenses | ---- | -13.99%-35.08M | ---- | -35.48%-112.34M | ---- | -159.34%-30.78M | ---- | -10.33%-82.92M | ---- | 3.02%-11.87M |
Profit from asset sales | ---- | ---- | ---- | 140.87%434K | ---- | ---- | ---- | -101.34%-1.06M | ---- | -26,675.00%-1.06M |
Revaluation surplus | ---- | --1K | ---- | ---- | ---- | ---- | ---- | -93.33%1.82M | ---- | -176.00%-17.1M |
-Changes in the fair value of other assets | ---- | --1K | ---- | ---- | ---- | ---- | ---- | -93.33%1.82M | ---- | -176.00%-17.1M |
Impairment and provision | ---- | -1.61%47.34M | ---- | -7.72%-288.54M | ---- | 162.54%48.11M | ---- | -146.91%-267.86M | ---- | ---76.93M |
-Other impairment is provision | ---- | -1.61%47.34M | ---- | -7.72%-288.54M | ---- | 162.54%48.11M | ---- | -146.91%-267.86M | ---- | ---76.93M |
Special items of operating profit | -17.15%28.58M | 1.61%-47.34M | 56.89%97.39M | -11.18%-680.66M | 2.37%34.49M | -29,798.77%-48.11M | -70.59%62.08M | -176.23%-612.22M | -77.69%33.69M | -99.94%162K |
Adjustment items of operating profit | ---- | 71.93%-30.68M | ---- | 10.17%484.38M | ---- | ---109.3M | ---- | --439.66M | ---- | ---- |
Operating profit | 86.13%-167.37M | 138.67%86.02M | 54.39%-1.75B | 65.85%-949.79M | -76.18%-1.21B | -234.81%-222.43M | -368.35%-3.84B | -224.74%-2.78B | -191.93%-684.84M | -88.14%165M |
Financing income | -2.28%180.84M | ---- | -29.13%383.99M | ---- | -43.81%185.05M | ---- | 6.50%541.83M | ---- | 32.35%329.31M | ---- |
Financing cost | -65.45%-91.9M | -29.53%43.2M | -47.52%-145.31M | -52.25%178.66M | -11.00%-55.55M | -58.27%61.3M | -4.58%-98.5M | 31.64%374.14M | -30.66%-50.04M | 29.46%146.9M |
Special items of earning before tax | 180.15%90.86M | 18.63%-2.57M | 18.71%-141.13M | 44.76%-26.66M | -311.68%-113.36M | -373.33%-3.16M | -119.86%-173.62M | 21.54%-48.26M | -104.69%-27.54M | 133.06%1.16M |
Earning before tax | 101.04%12.43M | 177.09%126.65M | 53.68%-1.66B | 67.51%-797.8M | -174.85%-1.19B | -152.48%-164.28M | -231.33%-3.57B | -200.12%-2.46B | -128.07%-433.11M | -79.14%313.05M |
Tax | -102.69%-6.1M | -2,241.27%-41.46M | -58.15%306.09M | -82.28%81.14M | 1,828.97%226.29M | 101.97%1.94M | 213.50%731.46M | 195.19%457.77M | 104.49%11.73M | 69.85%-98.2M |
After-tax profit from continuing operations | 100.66%6.33M | 152.48%85.2M | 52.53%-1.35B | 64.12%-716.66M | -128.80%-964.1M | -175.56%-162.35M | -236.87%-2.84B | -201.32%-2B | -132.88%-421.38M | -81.72%214.85M |
Earning after tax | 100.66%6.33M | 152.48%85.2M | 52.53%-1.35B | 64.12%-716.66M | -128.80%-964.1M | -175.56%-162.35M | -236.87%-2.84B | -201.32%-2B | -132.88%-421.38M | -81.72%214.85M |
Minority profit | 34.54%3.49M | 42.46%1.13M | -182.07%-3.17M | -38.11%2.79M | -49.90%2.59M | -40.60%796K | 21.54%3.86M | -29.06%4.51M | -0.15%5.17M | -25.14%1.34M |
Profit attributable to shareholders | 100.29%2.85M | 151.53%84.06M | 52.70%-1.35B | 64.06%-719.45M | -126.63%-966.69M | -176.41%-163.14M | -237.26%-2.85B | -201.88%-2B | -133.42%-426.55M | -81.81%213.51M |
Basic earnings per share | 100.34%0.0003 | 153.33%0.008 | 52.47%-0.125 | 63.78%-0.067 | -129.49%-0.0895 | -175.00%-0.015 | -236.98%-0.263 | -201.65%-0.185 | -133.05%-0.039 | -81.48%0.02 |
Diluted earnings per share | 100.34%0.0003 | 153.33%0.008 | 52.47%-0.125 | 63.78%-0.067 | -129.49%-0.0895 | -175.00%-0.015 | -236.98%-0.263 | -201.65%-0.185 | -133.05%-0.039 | -81.48%0.02 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership), KPMG Certified Public Accountants | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership), KPMG Certified Public Accountants | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data